1952
post-template-default,single,single-post,postid-1952,single-format-standard,strata-core-1.1.1,strata-child-theme-ver-1.0.0,strata-theme-ver-3.4,ajax_fade,page_not_loaded,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

Second phase of Thames Valley Science Park gets planning go-ahead

16:38 08 May in Uncategorized

Outline planning consent was recently granted for the second phase of the Thames Valley Science Park, owned by the University of Reading. This will see the development of the remaining 600,000 sqft of the total 800,000 sqft site. Approximately 15 new buildings will be developed as and when required over a 20-year period.

The ‘Gateway’ building, is due to open, fully occupied, later this year. It will provide 70,000 sqft of specialist space for approximately 20 innovative technology-based companies that are researching and delivering cutting-edge new products.

The second building, an innovative cancer treatment centre being built by Proton Partners International, is expected to open in the first half of 2018. The company, formed by UK-based and international cancer specialists, is investing £30 million to build its own purpose-built centre which will help meet growing demand for proton beam therapy, a specialised type of cancer treatment that is not yet available in the UK.

David Gilham, Director of Thames Valley Science Park, said: “Thames Valley Science Park is really taking shape.  The additional new consent will enable us to contribute to and help strengthen the position of the Thames Valley as one of Europe’s premier destinations for foreign-direct investment (FDI) and our ambitious, long-term plans, to continue to expand our region’s thriving community of knowledge-based companies.

The Science Park will primarily focus on attracting technology and life-sciences companies as a core component of the University vision for the Science Park in the years to come. David continues, “The Thames Valley is a significant, and proven, hot-bed for technology companies and part of the UK’s global renowned life sciences cluster known as the ‘golden triangle’. The Science Park now provides significant new space for any company to consider as the destination for their business.  It’s close to London, with all the benefits, but without the cost, and – importantly – provides truly great access to some of the UK’s and Europe’s best academic and commercial partners and networks.”

Paul Britton, CEO at the Thames Valley Chamber of Commerce added: “Thames Valley Science Park will provide a significant boost to the inward investment proposition for the healthcare sector in the Thames Valley and provide established and fledgling businesses with much needed flexible laboratory space.”

For more information on the Thames Valley Science Park, visit www.tvsp.co.uk